Vancomycin intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia

被引：0
|
作者：
Anderson, D
Naimi, TS
O'Boyle, C
Boxrud, DJ
Johnson, S
Tenover, FC
Lynfield, R
机构：
[1] Abbott NW Hosp, Wayzata, MN USA
[2] Minnesota Dept Hlth, Minneapolis, MN USA
[3] CDC, Atlanta, GA 30333 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
13
引用
收藏
页码：1090 / 1090
页数：1
相关论文
共 50 条
  • [1] Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia
    Naimi, TS
    Anderson, D
    O'Boyle, C
    Boxrud, DJ
    Johnson, SK
    Tenover, FC
    Lynfield, R
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) : 1609 - 1612
  • [2] Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia
    Khosrovaneh, A
    Riederer, K
    Saeed, S
    Tabriz, MS
    Shah, AR
    Hanna, MM
    Sharma, M
    Johnson, LB
    Fakih, MG
    Khatib, R
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) : 1328 - 1330
  • [3] Susceptibility of vancomycin resistant enterococci, methicillin resistant Staphylococcus aureus and vancomycin intermediate staphylococci to linezolid
    Garganera, DAC
    Carey, R
    O'Keefe, JP
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
  • [4] Case Series of Staphylococcus aureus Bacteremia With Discordant Genotypic and Phenotypic Categorization of Methicillin Susceptibility
    Gulliver, Jessica
    Jung-Hynes, Brittney
    Chen, Derrick J.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2020, 28 (06) : 371 - 374
  • [5] Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
    Rotun, SS
    McMath, V
    Schoonmaker, DJ
    Maupin, PS
    Tenover, FC
    Hill, BC
    Ackman, DM
    EMERGING INFECTIOUS DISEASES, 1999, 5 (01) : 147 - 149
  • [6] Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia
    Schwaber, MJ
    Wright, SB
    Carmeli, Y
    Venkataraman, L
    DeGirolami, PC
    Gramatikova, A
    Perl, TM
    Sakoulas, G
    Gold, HS
    EMERGING INFECTIOUS DISEASES, 2003, 9 (06) : 657 - 664
  • [7] Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin
    Wong, SSY
    Ng, TK
    Yam, WC
    Tsang, DNC
    Woo, PCY
    Fung, SKS
    Yuen, KY
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (04) : 261 - 268
  • [8] Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus
    Bennett, Jason W.
    Murray, Clinton K.
    Holmes, Robert L.
    Patterson, Jan E.
    Jorgensen, James H.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (04) : 437 - 440
  • [9] The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
    Honda, Hitoshi
    Doern, Christopher D.
    Michael-Dunne, Wm, Jr.
    Warren, David K.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [10] Prior Vancomycin Use Is a Risk Factor for Reduced Vancomycin Susceptibility in Methicillin-Susceptible but Not Methicillin-Resistant Staphylococcus aureus Bacteremia
    Mascitti, Kara B.
    Edelstein, Paul H.
    Fishman, Neil O.
    Morales, Knashawn H.
    Baltus, Andrew J.
    Lautenbach, Ebbing
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (02): : 160 - 166
12345